555 Performance of surveillance cultures at different body sites for Staphylococcus aureus in pregnant women and neonates

Sunday, April 3, 2011
Trinity Ballroom (Hilton Anatole)
Maria A. Cursino , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Cilmara P. Garcia , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Matias C. Salomão , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Renata D. Lobo , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Vera L. Krebs , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
M. Augusta Gibelli , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Mario M. Kondo , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Marcelo Zugaib , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Kleiste G. Keil , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Carla H. Molaco , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Robson E. Soares , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Paula D. Malieno , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Satiko Gobara , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Grabriela F. Raymundo , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Juliana F. Rosa , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Silvia F. Costa , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Anna Levin, MD , HOSPITAL DAS CLINICAS, Sao Paulo - SP, Brazil
Background: Dissemination of S. aureus, whether methicillin-susceptible (MSSA) or resistant (MRSA), occurs from person to person. In the hospital setting this may occur from patient to patient during patient care or through direct contact such as mother and child contact. Detection of asymptomatic carriers, especially of MRSA, has been suggested by some authors as a strategy to control nosocomial transmission. Thus asymptomatic carriers can be identified and put under contact precautions.

Objective: To evaluate the performance of surveillance cultures at different body sites in the detection of colonization by S. aureus.

Methods: From February 2009 through January 2010, pregnant women (PW) were submitted to surveillance cultures during labor (anterior nares; perineum; anus and oropharynx). Their neonates (NN) were cultured at birth, 3rd day, one week and weekly until discharge or the 4th week (whichever occurred first) at the sites: anterior nares; oropharynx; perineum and umbilicus. The swabs in Stuart’s medium were taken to the laboratory where they were cultured in BHI, incubated at 35o C and after 24h plated on mannitol salt agar then incubated for 48 h. Suspected S. aureus colonies were submitted to oxacillin resistance screening test with 6 µg/ml of oxacillin. Broth microdilution was used to determine the MIC for oxacillin.PCR was used to determine mecA and coa genes. Only the first occasion on which S. aureus isolation occurred was considered for each patient.

Results: 384 pregnant women were cultured (184 were positive for S. aureus-49%) and 378 neonates (207 were positive -54%). Thirty-two NN and 15 PW carried MRSA (8% of NN and 4% of PW). The positivity of each body site can be seen in the Table. Combining cultures sites such as nares and umbilical cultures in neonates led to 85% positivity for MSSA and 91% for MRSA. For PW, combining nares with the oropharynx led to 81% positivity for MSSA. For MRSA in PW, positivity of 80 % occurred by combining cultures of the nares with any other site.

Conclusions: Surveillance cultures of one body site are insufficient to detect a large proportion of colonized neonates and pregnant women. Combining cultures of 2 body sites will improve positivity but there will be 9-20% of carriers who will remain undetected. Thus, control of S.aureus relying mainly on surveillance cultures may be jeopardized.

Table: Positivity of surveillance cultures for Staphylococcus aureus at different body sites of pregnant women and neonates.

Neonates 

 

 

 

 

 

Nares

Oropharynx

Perineum

Umbilicus

Methicillin-susceptible S. aureus (n: 152)

91 (60%)

65 (43%)

82 (54%)

92 (61%)

Methicillin-resistant S. aureus (n: 32)

15 (47%)

13 (41%)

23 (72%)

23 (72%)

Pregnant women

 

 

 

 

 

Nares

Oropharynx

Perineum

Anus

Methicillin-susceptible S. aureus (n: 192)

110 (57%)

97 (51%)

47 (25%)

46 (25%)

Methicillin-resistant S. aureus (n: 15)

10 (67%)

7 (47%)

3 (20%)

3 (20%)

 Funding FAPESP 2009/08206-1.